This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Energy Fuels Set to Report Q3 Earnings: Buy, Sell or Hold the Stock?
by Madhurima Das
UUUU's Q3 results are likely to show strong uranium sales but rising costs could pressure earnings.
Cameco (CCJ) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Cameco (CCJ) settling at $104.72, representing a -1.83% change from its previous close.
Cameco (CCJ) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Cameco (CCJ) stood at $88.13, denoting a +2.12% move from the preceding trading day.
Cameco (CCJ) Stock Moves -3.64%: What You Should Know
by Zacks Equity Research
Cameco (CCJ) concluded the recent trading session at $82.77, signifying a -3.64% move from its prior day's close.
Wall Street Analysts See Cameco (CCJ) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cameco (CCJ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LEU vs. CCJ: Which Stock Has More Power for Growth Right Now?
by Madhurima Das
As nuclear demand surges worldwide, Centrus Energy and Cameco stand out, but Centrus' HALEU edge makes it the brighter investment bet.
Can CCJ Meet Its FY25 Uranium Sales Target Amid Production Constraints?
by Madhurima Das
Cameco projects 2025 uranium revenues of CAD 2.8-3.0B, driven by higher realized prices despite lower production from McArthur River.
Centrus Energy's Revenues Slip 2% in 1H25: Recovery Ahead?
by Madhurima Das
LEU's 1H25 revenues dip 2% as weak uranium sales offset solid gains in its Technical segment.
Cameco (CCJ) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Cameco (CCJ) stood at $93.19, denoting a +1.13% move from the preceding trading day.
UEC Soars 114% in the Past Three Months: How to Play the Stock?
by Madhurima Das
Uranium Energy's debt-free position and production ramp-up fuel optimism, but its steep valuation and widening losses raise caution flags.
Cameco Rallies 116% in 6 Months: How to Play the Stock?
by Madhurima Das
CCJ stock surges 115.9% in six months on strong H1 results and a Slovakia supply deal.
Is UUUU Stock a Buy, Hold or Sell After Its 194% Three-Month Rally?
by Madhurima Das
Energy Fuels surges 194% on rare earth milestones, record uranium output and a debt-free balance sheet supporting long-term growth potential.
Cameco (CCJ) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Cameco (CCJ) closed at $85.31, indicating a +1.35% shift from the previous trading day.
LEU's Premium Valuation: Is the Stock a Buy, Hold or Sell Now?
by Madhurima Das
Centrus Energy's soaring stock, HALEU leadership and U.S. expansion plans fuel optimism despite high valuation and rising debt.
These 2 Nuclear Stocks Have Been Red Hot in 2025
by Derek Lewis
Nuclear stocks reflect meaningful exposure to the AI trade thanks to the vast amount of power used in data centers.
Can Energy Fuels Capitalize on the Recent Gain in Uranium Prices?
by Madhurima Das
UUUU's H125 revenues sink 38% on weaker uranium sales, but rising uranium prices and hefty inventory may set up stronger future gains.
Here's Why Cameco (CCJ) Fell More Than Broader Market
by Zacks Equity Research
In the most recent trading session, Cameco (CCJ) closed at $83.09, indicating a -4.37% shift from the previous trading day.
CCJ vs. URG: Which Uranium Stock is the Better Buy Today?
by Madhurima Das
Cameco's scale and fuel-cycle diversification outshine Ur-Energy's growth prospects, making it the stronger uranium play in a bullish market.
Centrus Energy's Costs Drop 27% in H1: Can It Maintain the Momentum?
by Madhurima Das
LEU's lower costs fuel 113% gross profit surge in the first half of 2025, in contrast to the steep expense pressures of the last year.
UEC Gears Up to Report Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Uranium Energy is set to post Q4 results on Sept. 24, with $17M in expected revenues and a projected loss of three cents per share.
Cameco Expands Global Reach With Slovakia Deal: A Growth Catalyst?
by Madhurima Das
CCJ secures a long-term deal with Slovakia's largest electricity producer, marking its entry into Slovakia's nuclear fuel market.
Cameco (CCJ) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Cameco (CCJ) settling at $78.11, representing a -2.23% change from its previous close.
Cameco's Premium Valuation: Is the Stock a Buy, Hold or Sell Now?
by Madhurima Das
CCJ posts strong Q2 results with soaring uranium sales, but faces a premium valuation and trimmed McArthur River output.
Uranium Demand to Jump 28%: ETFs in Focus
by Yashwardhan Jain
Uranium demand could surge nearly 30% in five years, fueled by AI-driven energy needs and nuclear power's clean energy edge.
LEU's Gross Profit Jumps 113% in H125: Can Momentum Carry Forward?
by Madhurima Das
Centrus Energy's gross profit more than doubles in the first half of 2025, fueled by lower costs despite softer revenues.